C

    CLARIVATE PLC (CLVT)

    Official site

    TECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE

    $2.06
    +0.04 (+1.73%)

    Market Cap: $1.31B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(29/40)
    Avg Surprise
    -206.15%
    Streak
    23 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.16
    Range$0.16 - $0.16
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$0.18+14.7%
    60d ago$0.18+14.8%
    30d ago$0.18+14.8%
    7d ago$0.17+6.0%
    Current$0.16
    Revenue Consensus
    $490M
    Range$490M - $490M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.23
    Range$0.23 - $0.23
    2 analysts
    Revenue Consensus
    $520M
    Range$520M - $520M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.23---
    Sep 26EST
    		-$0.16---
    Jun 26
    Reported Jul 29
    		$0.17$0.14+21.43%Beat-5.6%
    Mar 26
    Reported Apr 29
    		$0.18$0.14+28.57%Beat+28.6%
    Dec 25
    Reported Feb 24
    		$0.20$0.17+20.63%Beat-4.8%
    Sep 25
    Reported Oct 29
    		$0.18$0.16+12.50%Beat-5.3%
    Jun 25
    Reported Jul 30
    		$0.18$0.17+5.88%Beat-10.0%
    Mar 25
    Reported Apr 29
    		$0.14$0.12+16.67%Beat+0.0%
    Dec 24
    Reported Feb 19
    		$0.21$0.20+3.75%Beat-8.7%
    Sep 24
    Reported Nov 6
    		$0.19$0.18+5.56%Beat-9.5%
    Jun 24
    Reported Aug 6
    		$0.20$0.18+11.11%Beat-4.8%
    Mar 24
    Reported May 8
    		$0.14$0.14+0.00%Beat-22.2%
    Dec 23
    Reported Feb 27
    		$0.23$0.21+9.52%Beat+4.5%
    Sep 23
    Reported Nov 7
    		$0.21$0.18+16.67%Beat+5.0%
    Jun 23
    Reported Aug 3
    		$0.21$0.20+5.00%Beat-4.5%
    Mar 23
    Reported May 9
    		$0.18$0.15+20.00%Beat-14.3%
    Dec 22
    Reported Mar 1
    		$0.22$0.17+29.41%Beat-4.3%
    Sep 22
    Reported Nov 8
    		$0.20$0.17+17.65%Beat+25.0%
    Jun 22
    Reported Aug 9
    		$0.22$0.20+10.00%Beat+29.4%
    Mar 22
    Reported May 9
    		$0.21$0.18+16.67%Beat+50.0%
    Dec 21
    Reported Mar 10
    		$0.23$0.21+9.52%Beat+4.5%
    Sep 21
    Reported Oct 28
    		$0.16$0.16+0.00%Beat+14.3%
    Jun 21
    Reported Jul 29
    		$0.17$0.17+0.00%Beat-5.6%
    Mar 21
    Reported May 10
    		$0.14$0.12+16.67%Beat+100.0%
    Dec 20
    Reported Feb 25
    		$0.22$0.17+29.41%Beat+69.2%
    Sep 20
    Reported Oct 29
    		$0.14$0.15-6.67%Miss+0.0%
    Jun 20
    Reported Jul 30
    		$0.18$0.14+28.57%Beat+550.0%
    Mar 20
    Reported May 4
    		$0.07$0.09-22.22%Miss+100.7%
    Dec 19
    Reported Feb 27
    		$0.13$0.16-18.75%Miss+244.4%
    Sep 19
    Reported Nov 5
    		$0.14$0.06+133.33%Beat+1500.0%
    Jun 19
    Reported Aug 7
    		$-0.04N/A+77.78%Beat-
    Mar 19
    Reported Apr 26
    		$-9.69$0.12-8175.00%Miss-
    Dec 18
    Reported Feb 27
    		$-0.09$0.16-156.25%Miss-160.0%
    Sep 18
    Reported Nov 5
    		$-0.01N/A-105.26%Miss-105.9%
    Jun 18
    Reported Aug 3
    		$0.00N/A-100.00%Miss-100.0%
    Mar 18
    Reported Jun 29
    		$0.00N/A-100.00%Miss-100.0%
    Dec 17
    Reported Mar 30
    		$0.15$0.15+0.00%Beat-6.3%
    Sep 17
    Reported Nov 6
    		$0.17$0.16+6.25%Beat+30.8%
    Jun 17
    Reported Aug 4
    		$0.14$0.19-26.32%Miss-
    Mar 17
    Reported May 9
    		$0.02N/A-87.50%Miss-
    Dec 16
    Reported Feb 24
    		$0.16$0.15+6.67%Beat-
    Sep 16
    Reported Nov 3
    		$0.13$0.14-7.14%Miss-

    Key Metrics

    Valuation
    P/E Ratio2.82EV/EBITDA8.02x
    Price/FCF4.01xFCF Yield24.93%
    Profitability
    Profit Margin-13.80%Operating Margin6.13%
    ROE-7.01%ROIC0.81%
    Financial Health
    Debt/Equity0.93xInterest Coverage0.27x
    Current Ratio0.85xQuick Ratio0.85x
    Trading Statistics
    Beta1.39Avg Volume4.45M
    52-Week High$4.5452-Week Low$1.66

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.05
    SMA 20$1.97
    SMA 50$2.10
    SMA 200$2.59
    EMA 10$2.03
    EMA 20$2.03
    EMA 50$2.11
    EMA 200$2.60

    MACD

    Line: -0.01Signal: -0.03Hist: 0.02

    ADX

    ADX: 10.1+DI: 18.3-DI: 19.5

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down8.0
    PSAR$2.19

    Bollinger Bands

    Upper Band$2.17
    Lower Band$1.78
    %B Position1953%(Upper)
    Band Width0.71

    RSI (14-Day)

    Neutral
    50.7

    Momentum Oscillators

    Stoch %K60.6
    Stoch %D62.3
    Williams %R-34.8
    ROC (10d)8.7%
    Momentum0.17
    CCI (20d)48.6
    MFI (14d)66.5

    Volatility Measures

    ATR (14d)$0.14(6.7%)
    StdDev (20d)0.10
    Hist Vol54.9%(High)

    Volume Flow

    VWAP$2.03
    OBV18.5M
    AD Line-45.7M
    CMF (20d)-0.029

    Volume Metrics

    Avg Vol (20d)4.3M
    Vol Ratio0.8x
    VWMA (20d)$1.97

    Pivot Points

    R3$2.14
    R2$2.10
    R1$2.06
    Pivot Point$2.02
    S1$1.98
    S2$1.94
    S3$1.90

    Advanced Oscillators

    TSI-2.43
    Ultimate Osc51.7
    KST-43.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$587.30M$585.50M$617.00M$623.10M$621.40M$593.70M$663.00M$622.20M$650.30M$621.20M$683.70M$647.20M
    Cost of Revenue$185.50M$192.10M$204.80M$218.20M$203.60M$207.00M$227.70M$210.10M$213.60M$217.80M$231.90M$220.60M
    Gross Profit$401.80M$393.40M$412.20M$404.90M$417.80M$386.70M$435.30M$412.10M$436.70M$403.40M$451.80M$426.60M
    Operating Expenses$602.00M$363.20M$370.80M$360.90M$410.90M$407.50M$497.60M$390.40M$676.70M$398.40M$1.24B$339.40M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$181.60M$176.30M$179.10M$170.00M$181.10M$178.40M$180.80M$169.70M$185.20M$191.90M$180.10M$171.90M
    Operating Income$-200,200,000$30.20M$41.40M$44.00M$6.90M$-20,800,000$-62,300,000$21.70M$-240,000,000$5.00M$-788,200,000$87.20M
    Interest Income$-60,400,000$-59,000,000$-66,000,000$-68,500,000$-66,600,000$-64,300,000$-69,900,000$-72,200,000$-71,100,000$-70,200,000$-75,200,000$-71,900,000
    Interest Expense$60.40M$59.00M$66.00M$68.50M$66.60M$64.30M$69.90M$72.20M$71.10M$65.00M$73.70M$59.30M
    Income Before Tax$-260,600,000$-28,800,000$-24,600,000$-24,500,000$-59,700,000$-85,100,000$-132,200,000$-50,500,000$-311,100,000$-60,000,000$-861,900,000$27.90M
    Income Tax Expense$8.00M$11.40M$-27,700,000$3.80M$12.30M$18.80M$59.60M$15.10M$-6,800,000$15.00M$-18,000,000$15.60M
    Net Income$-268,600,000$-40,200,000$3.10M$-28,300,000$-72,000,000$-103,900,000$-191,800,000$-65,600,000$-304,300,000$-75,000,000$-843,900,000$12.30M
    EBITDA$-11,200,000$217.50M$233.50M$239.40M$202.60M$167.50M$129.00M$202.10M$-52,400,000$194.30M$-600,600,000$280.40M
    EBIT$-200,200,000$30.20M$41.40M$44.00M$6.90M$-20,800,000$-62,300,000$21.70M$-240,000,000$10.20M$-786,700,000$99.80M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CLVT

    Government Contracts

    Gov Obligations (TTM)
    $69.02M
    Gov Obligations / Revenue
    2.9%
    Obligations YoY
    -32.0%
    Active Awards
    354
    New Awards (TTM)
    123
    Avg Remaining Term
    7.7 mo

    Top agency: Department of the Treasury at 11.8% of trailing twelve month obligations across 52 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    2023H226P00094Department of the TreasuryInternal Revenue Service$5.93MJan 1, 2026
    70RDA226FR0000007Department of Homeland SecurityOffice of Procurement Operations$5.44MApr 2, 2026
    7571MN26F80052Department of Health and Human ServicesOffice of the Assistant Secretary for Financial Resources$3.01MJun 1, 2026
    1333BJ26P00280001Department of CommerceU.S. Patent and Trademark Office$1.29MJan 30, 2026
    15A00026CAQA00039Department of JusticeBureau of Alcohol, Tobacco, Firearms and Explosives Acquisition and Property Management Division$777468Mar 1, 2026
    12314426P0025Department of AgricultureOffice of the Chief Financial Officer$695843Apr 1, 2026
    693JK426F55012NDepartment of TransportationImmediate Office of the Secretary of Transportation$412800Jul 1, 2026
    77344425P0008U.S. International Development Finance CorporationU.S. International Development Finance Corporation$323208Dec 1, 2025
    89303025PGC000027Department of EnergyDepartment of Energy$318156Oct 1, 2025
    33330225CF0010468Smithsonian InstitutionSmithsonian Institution$312834Sep 29, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

    Clarivate Plc Director Kenneth L. Cornick purchased 900,000 shares of the company's stock for $1.7 million, increasing his total holdings by 74% to approximately 2.1 million shares. This significant insider buying, executed through Cornick Family Investor, LLC, signals a bullish outlook despite the stock's 52% decline over the past year and analysts' projections of declining sales. Management believes recent restructuring and the sale of non-core divisions will lead to more predictable revenue and long-term growth.

    The Globe and Mail•8/19/26•
    Bullish

    Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

    Clarivate Director Kenneth L. Cornick recently purchased 900,000 shares of Clarivate Plc (NYSE:CLVT) for $1.7 million, increasing his total holdings by 74%. This significant insider purchase suggests a bullish outlook despite the stock's 52% decline over the past year and analyst predictions of declining sales. Management anticipates modest growth of about 2% for 2026 after selling non-core divisions, a strategy Cornick seems to endorse.

    The Globe and Mail•8/18/26•
    Bullish

    AI in healthcare: Are you tracking the right competitors?

    This article discusses how patent intelligence can reveal unexpected competitors in the rapidly evolving field of AI in healthcare. It highlights that medical technology companies are leading in AI-related patent filings, and relevant AI capabilities are emerging from diverse industries such as computing and digital platforms, not just traditional life sciences. The author suggests that IP teams should track technologies across industry boundaries to identify potential partners, acquisition targets, or competitive threats early on.

    Clarivate•8/18/26•
    Neutral

    CLVT|Clarivate PLC|Price:1.923|Chg%:-0.037

    This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with a target price indicating a significant upside potential.

    TradingKey•8/14/26•
    Neutral

    ETFs Investing in Clarivate PLC Stocks

    This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return. The ETFs predominantly focus on small-cap, value, and extended market strategies.

    TradingView•8/14/26•
    Neutral

    Frequently Asked Questions About CLVT

    Does CLVT pay dividends?
    CLARIVATE PLC (CLVT) does not currently pay a regular dividend.
    What is CLVT's P/E ratio?
    CLARIVATE PLC has a price-to-earnings (P/E) ratio of 2.82.
    What is CLVT's market cap?
    CLARIVATE PLC (CLVT) has a market capitalization of $1.31B with a current stock price of $2.06.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In